New Journal for ImmunoTherapy of Cancer article: Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinoma bit.ly/4lcxHLC
@riyuesunnybao.bsky.social @pancpathologist.bsky.social
@zervanto.bsky.social @jasonlukemd.bsky.social
#JITC #cancer #MedSky
🔥 Great discussion at the in person meeting of the GLOBAL GUIDELINES FOR CYSTIC TUMORS OF THE PANCREAS
expected to be released 🔜 stay tuned!
@letswinpc.org #HPBSky
A huge majority of Americans (77%) oppose the cuts to medical research that the current administration has made.
(Source: Wash. Post/ABC/Ipsos poll)
A little late, but what a wonderful time supporting #PancreaticCancer research at @pancan.bsky.social purplestride in Pittsburgh. @news.upmc.com @upmc.com @upmchillmancc.bsky.social
If you or someone you love has been diagnosed with #pancreaticcancer, you’re not alone — we’re here to help. 💜 Our educational packets include essential resources to help you navigate next steps. Access these materials digitally 🖥️ or have them mailed to you 📬 by visiting pcan.at/skpmuj.
This is catastrophic for pancreatic cancer patients
Truly unfortunate. But great image. Would love to evaluate by whole transcriptome to see differences between these neoplasms as opposed to conventional CRC have...
Nice case! MSS or MSI?
In HER2-positive early #breastcancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival
Check out the full story 👇
www.curetoday.com/view/kadcyla...
Our incredible Team PanCAN runners are lacing up for the LA Marathon and Charity Half Marathon, and the United Airlines NYC Half Marathon today! 💜🏃♂️ They’ve spent months training and fundraising to make a difference for pancreatic cancer patients. Let’s show them some love in the comments!
Serous Cystadenoma HOP with Vascular Map
💥 A Stellar episode of our virtual meeting on pancreas topic.. this time IPMN 🍇 !!!
🚨 Integrating molecular testing to the evaluation of Pancreatic Cyst with the great @pancpathologist.bsky.social 🇺🇸 @upmc.bsky.social
Thank you, Aatur Singhi, for such a Christmas gift!!! 🎄
youtu.be/fF7HcPCqiwk
Benign Pancreatic Tumors
Read more here: ctisus.com/learning/fea...
More data on role of ATRX/DAXX loss for surgery in pancreas #NETs
👥116 PNETs in 🇯🇵
🧬11% DAXX & 7% ATRX loss 👉🏻intratumoral heterogeneity in 1/3
⬇️RFS with ATRX/DAXX loss
Should it be done routinely on all PNETs?
🔗 pubmed.ncbi.nlm.nih.gov/38909708/
#NETsSky #HPBSky #SurgSky #PancSky
PNET: CT Findings
ctisus.com/learning/fea...
Pancreatic Paraganglioma: CT Findings
ctisus.com/learning/fea...
Is the other ALT (alternative lengthening of telomeres) ready for use in pNETs..? I think so, especially for prognostication after resection. Chromogenic ISH (CISH) easier to implement than FISH. Excellent stuff from Chris Heaphy, Aatur Singhi et al.
www.sciencedirect.com/science/arti...
